Ocumetics Achieves Key Milestone: Laboratory Testing Confirms Accommodative Power Target was Successfully Achieved in Preparation for First-in-Human Trials

Core Insights - Ocumetics Technology Corp. has achieved a significant breakthrough in the development of next-generation intraocular lens technology, demonstrating accommodative power change in laboratory testing [1][2] - The company plans to prepare for first-in-human studies scheduled for summer 2025, following successful laboratory results [2][3] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company focused on advanced vision correction solutions aimed at enhancing patients' quality of life [4] - The company is dedicated to transforming the field of ophthalmology through innovative research and development of state-of-the-art intraocular lenses and other vision-enhancing technologies [4] Technological Development - The intraocular lens developed by Ocumetics is designed to fit within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses [5] - This lens allows the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the assistance of glasses or contact lenses [5] Research and Development - The testing utilized Ocumetics' Lens Analyzer (IOLA) bench testing platform to simulate ciliary body pressures, confirming the lens's ability to respond dynamically [2][3] - The company continues to collaborate with leading ophthalmic researchers, engineers, and clinical advisors to advance its rigorous R&D roadmap [3]